Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biosimilar Antitrust Pressure On J&J Grows As Walgreen, Kroger Sue Over Remicade Contracts

Executive Summary

Pharmacy chains object to J&J agreements with insurers that block coverage of Pfizer and Merck biosimilars except in 'rarest of circumstances'; seek overcharge damages for Remicade purchases.
Advertisement

Related Content

Pointing Fingers On Biosimilars: FDA Versus FTC
Pointing Fingers On Biosimilars: FDA Versus FTC
Biosimilar Substitution: US State Laws Require Physician Communication And, In Some Cases, Lower Prices
Biosimilar Substitution: US State Laws Require Physician Communication And, In Some Cases, Lower Prices
Pfizer v. J&J Sets Stage For Biosimilar Showdown Over Exclusive Contracts

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS123257

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel